• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Quest Diagnostics Launches Genetic Test to Assess Risk for Sickle Cell Anemia, Other Inherited Disorders

Couples who wish to know the risk of passing on a genetic disease such as sickle cell anemia to their children may now do so with QHerit, a new screening test by Quest Diagnostics.

The QHerit Pan-Ethnic Expanded Carrier Screen test covers 22 genetic diseases and was produced based on screening guidelines issued in March 2017 by the American College of Gynecology (ACOG). The test determines the likelihood of a couple passing on a heritable disorder to their children and its impact.

The test is able to predict the occurrence of diseases such as sickle cell anemia, cystic fibrosis, thalassemia, Joubert Syndrome 2, Tay-Sachs disease, and Fragile X syndrome, among others.


To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.